The cytomegalovirus resistance locus Cmv3 has been linked to an epistatic interaction between two loci: a Natural Killer (NK) cell receptor gene and the major histocompatibility complex class I (MHC-I) locus. To demonstrate the interaction between Cmv3 and H2k, we generated double congenic mice between MA/My and BALB.K mice and an F2 cross between FVB/N (H-2q) and BALB.K (H2k) mice, two strains susceptible to mouse cytomegalovirus (MCMV). Only mice expressing H2k in conjunction with Cmv3MA/My or Cmv3FVB were resistant to MCMV infection. Subsequently, an F3 cross was carried out between transgenic FVB/H2-Dk and MHC-I deficient mice in which only the progeny expressing Cmv3FVB and a single H2-Dk class-I molecule completely controlled MCMV viral loads. This phenotype was shown to be NK cell–dependent and associated with subsequent NK cell proliferation. Finally, we demonstrated that a number of H2q alleles influence the expression level of H2q molecules, but not intrinsic functional properties of NK cells; viral loads, however, were quantitatively proportional to the number of H2q alleles. Our results support a model in which H-2q molecules convey Ly49-dependent inhibitory signals that interfere with the action of H2-Dk on NK cell activation against MCMV infection. Thus, the integration of activating and inhibitory signals emanating from various MHC-I/NK cell receptor interactions regulates NK cell–mediated control of viral load.
Effective natural killer (NK) cell responses against virally infected cells are regulated by NK cell receptors that specifically recognize target cells. In the current study, we validated the specific interaction taking place between NK cell receptors and MHC class I molecules on the surface of infected cells, resulting in resistance to cytomegalovirus. Genetic dissection of this mechanism of interaction revealed that the NK cell response occurs exclusively through the triggering of the activating Ly49P receptor by the MHC class I H2-Dk molecule. We observed, in this context, that NK cells were incapable of clearing the virus when target cells also expressed MHC class I H2q molecules, which strongly and quantitatively inhibit NK cells. Our findings reveal that the interplay between inhibitory and activating NK cell receptors and their MHC class I ligands generate signals that shape the outcome of infection.
Citation: Fodil-Cornu N, Loredo-Osti JC, Vidal SM (2011) NK Cell Receptor/H2-Dk–Dependent Host Resistance to Viral Infection Is Quantitatively Modulated by H2q Inhibitory Signals. PLoS Genet 7(4): e1001368. https://doi.org/10.1371/journal.pgen.1001368
Editor: Derry C. Roopenian, The Jackson Laboratory, United States of America
Received: September 24, 2010; Accepted: March 8, 2011; Published: April 21, 2011
Copyright: © 2011 Fodil-Cornu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by Canadian Institutes of Health Research MOP-7781 and the Canada Research Chairs Program (SMV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Natural killer (NK) cells play an important role in the innate immune response against tumors, MHC-mismatched bone-marrow grafts, and pathogens –. These cells also contribute to defense against parasites and intracellular bacteria, and they are critical for the control of a variety of viral infections –. NK cell actions are immediate and appear to be particularly important during the first few days of infection; they involve direct lysis of infected cells and production of proinflammatory cytokines . NK cell activation is tightly regulated by output signals derived from the engagement of inhibitory and activating receptors by their respective ligands on potential targets . Inhibitory human killer immunoglobulin–like receptors (KIR), mouse killer C-type lectin-like receptors family A (KLRA or Ly49), and NKG2A/CD94 receptors recognize major histocompatibility (MHC) class I molecules (H2 in mice), thus controlling NK cell reactivity against “self.” As virally infected cells downregulate the expression of MHC class I molecules, the lack of inhibitory signals stimulates NK cells. This mechanism is described as the “missing self” hypothesis, whereby NK cells eliminate targets that lack normal levels of self-MHC class I molecules . In addition, the interaction between inhibitory receptors and self MHC-I molecules is the basis of NK cell education (also termed licensing), leading to the maturation of functional NK cells in homeostatic conditions –. By contrast, several families of activating receptors, such as activating KLRA (also known as Ly49) receptors, KLRK1 (NKG2D) and the natural cytotoxicity receptor (NCR) NKP46 (NCR1) can induce NK cell activation through the recognition of viral ligands or stress-induced molecules –. Although it is clear that NK cell responses are modulated by a balance of opposing signals received from self- or nonself-specific ligands, the precise contribution of specific inhibitory and activating pathways to the resolution of infection remains to be fully understood.
The genetic dissection of host resistance or susceptibility to mouse cytomegalovirus (MCMV) has provided a fresh view of the precise role of activating NK cell receptors in the recognition of infected cells and host protection against the infection. Using informative crosses between various mouse strain combinations, several MCMV-resistance loci have been mapped to the NK cell gene complex (NKC) on mouse chromosome 6. The best characterized, Cmv1 (also known as Klra8) and Cmv3, are defined by two different modes of inheritance, which seem to correlate with two different mechanisms of recognition. Cmv1 is a single dominant locus whose resistance allele, described in C57BL/6 (B6) mice, encodes the Ly49H activating receptor. Ly49H recognizes MCMV-infected cells through a direct interaction with the viral product m157 –. Engagement of Ly49H by m157 elicits NK cell–mediated cytotoxicity, cytokine secretion, NK cell proliferation, and viral clearance , –. The Cmv3 locus was detected in a cross between resistant MA/My and susceptible BALB/c mice. Expression of Cmv3-determined resistance accounted for a 100-fold decrease in splenic viral load, but it was only observed in mice carrying a specific combination of MA/My alleles at the NKC and MHC (H2k) loci. Functional candidate gene testing of Ly49 receptors isolated from MA/My mice showed that another DAP12-associated receptor, Ly49P, responded to MCMV-infected cells . In this case, Ly49P functional recognition of target cells required surface expression of both the host H2-Dk molecule and the viral component m04/gp34 . The role of the H2k haplotype in MCMV resistance was previously associated with greater survival following infection with lethal inoculum doses of MCMV compared to other H2 haplotypes . In addition, linkage analyses in a cross between resistant MA/My and susceptible C57L strains, as well as the generation of congenic C57L.M-H2k mice carrying the H2k allele from MA/My, confirmed a role for H2-Dk-linked resistance to MCMV –. Nevertheless, the mechanism of resistance regulated by the interaction between NK receptors and MHC class I molecule is still unclear.
In MA/My mice, Cmv3-determined MCMV resistance served as a model for researchers and allowed them to propose the existence of a functional interaction between the activating Ly49P receptor on NK cells and MHC class I H2-Dk molecules. However, the role of a Ly49P-m04-H2-Dk stimulatory axis remained to be clarified. In the present study, we sought to replicate experimentally the statistical association between the NKC and the MHC-I locus in MCMV resistance, to determine the precise molecules involved in MCMV resistance in vivo, and to evaluate the impact of MHC-I inhibitory signals on the NK cell antiviral response.
Interaction between NKC alleles and H2k locus is associated with resistance to MCMV
To validate the epistatic interaction between the NKC and H2 detected by linkage analysis , we used a marker-assisted strategy to construct congenic mouse lines in which a chromosome 6 segment (Cmv3) from MA/My MCMV-resistant mice was independently introgressed into BALB/c (H2d) and BALB.K (H2k) susceptible backgrounds. Congenic BALB.K mice have been described previously . The correlations between the current physical maps and the genomic region introgressed in the respective single and double congenic strains BALB-Cmv3MA/MyH2d and BALB-Cmv3MA/MyH2k are shown in Figure 1 and Table 1.
(A) Left, physical map of chromosome 6 markers used to determine the size of the MA/My fragment introgressed into the BALB background. The four versions of chromosome 6 indicate the genotypes of sub-congenic strains produced during the generation of BALB.Cmv3MA/My congenic mice carrying a 10 Mb segment (between SNPs rs13479016 and rs13479061) spanning the NKC region from parental MA/My mice. Right, physical map of chromosome 17 markers used to characterize the 9.4 Mb segment (between D17Mit28 and D17Mit51) comprising the H2 region of BALB.K mice (H2k). (B) NK cell receptor expression in MA/My parental mice and derived BALB-Cmv3MA/MyH2d and BALB-Cmv3MA/MyH2k congenic mice. The receptors (indicated on the bottom of the panel) were gated by FACS on NKp46+ splenic NK cells; the proportion of expression is indicated in each histogram. (C) Viral load in spleens (left) and livers (right) of mice of the indicated genotypes, as determined by plaque-forming assays 3 days p.i. (D) Spleen size (top) and weight and total cellularity (bottom) determined in MA/My and BALB-Cmv3MA/MyH2k mice at 7 days p.i. White bar, uninfected mice; black bar, MCMV-infected mice. Data were analyzed using two-way ANOVA analysis and the two-tailed Student's test. Data are presented as mean ± SEM and P values of significant differences between groups are indicated. Results shown in panel B are representative of three experiments using 2–3 mice per group; results shown in panels C and D are representative of five independent experiments using 3–8 mice per group.
To examine the effect of the genetic background on the expression of NKC-encoded receptors in the Cmv3MA/My region, we used a panel of antibodies with known antigen specificities (Figure S1) . Though several anti-Ly49 antibodies are cross-reactive , we observed variations among the mouse strains in terms of frequency of Ly49 subpopulations. Compared to BALB-Cmv3MA/MyH2d mice, BALB-Cmv3MA/MyH2k animals had a significantly increased frequency of NK cells stained with the monoclonal antibodies 12A8 (against Ly49R; P = 0.02) and 14B11 (against Ly49I/U; P = 0.007) (Figure 1B and Figure S2). Notably, 14B11-stained NK cells were also significantly increased in BALB-Cmv3MA/MyH2k mice compared to MA/My mice (P = 0.005). These results demonstrated the influence of H2 alleles , as well as the influence of an additional non-H2 mechanism, in the formation of the Ly49 repertoire. We also observed a highly significant increase in the frequency of NK cells labeled with 2F1 antibody (P = 0.004), which recognizes the maturation marker KLRG1, in BALB-Cmv3MA/MyH2d mice compared to their H2k counterparts. Finally, we observed that NK cells from the three mouse strains that share the Cmv3MA/My allele lacked expression of NKG2A/C/E and CD94-associated receptors at the protein but not mRNA level (Figure 1B and Figure S3B). By contrast, there was a normal expression of these receptors in the FVB/N mouse strain, which carries an NKC haplotype similar to that of MA/My mice (Figure S3A and S3B).
To evaluate the effect of the transferred MA/My chromosome 6 (Cmv3) segment on the response of MCMV-susceptible BALB/c and BALB.K mice, we infected congenic and parental control mice by intraperitoneal (i.p.) inoculation of MCMV sublethal doses (Figure 1C). By day 3 post-infection (p.i), uncontrolled MCMV replication was observed in the spleen of susceptible BALB/c mice (log10 plaque-forming units [PFU] = 4.39±0.16), while MCMV-resistant MA/My mice had restricted viral replication, as shown by a >100-fold lower viral titer (log10 PFU = 1.81±0.05) than that seen in BALB/c mice. Single congenic BALB.K and BALB-Cmv3MA/MyH2d mice had viral titers that were indistinguishable from those observed in BALB/c mice. More importantly, congenic mice with the BALB.K background, which carry only one copy of the MA/My NKC (BALB-NKCBALBCmv3MA/My.H2k), were as susceptible to MCMV as BALB/c, BALB.K, and BALB-Cmv3MA/MyH2d mice. By contrast, double congenic BALB-Cmv3MA/MyH2k mice had restricted virus growth to the same extent as resistant MA/My mice. Viral titers in the liver correlated with those observed in the spleens. Furthermore, by day 7 p.i., the virus was cleared from the spleen (unpublished data), which had undergone a massive increase in weight and cell number in MA/My and BALB-Cmv3MA/MyH2k mice (Figure 1D). Collectively, these data demonstrate that the interaction between Cmv3MA/My and H2k confers MCMV resistance and is sufficient to explain the control of viral load observed in MA/My mice.
Because we did not have antibodies that specifically recognize Ly49P receptors and to examine a possible role of CD94 heterodimers, we attempted to confirm the results obtained in the congenic mice in a new cross between two strains that independently carried the H2k loci and the Ly49P gene at the NKC. We examined the segregation of MCMV viral load in the spleens of progeny mice from an F2 cross between the MCMV-susceptible strains FVB/N and BALB.K. Although both parental strains sustained a relatively high viral titer (5.2 log10 PFU), the 137 F2 progeny showed a continuous distribution ranging from 2 to 6 log10 PFU (Figure 2A). To evaluate the contribution of H2 and NKC genes to MCMV resistance in this cross, F2 mice were genotyped and distributed according to their NKC (Ly49e) and H2 (IAA1) genotypes. Mice homozygous for H2kk alleles from BALB.K and NKCff alleles from FVB/N had the lowest viral load (Figure 2B). The model that best fitted this phenotype/genotype distribution in the analysis of variance had a joint logarithm of odds (LOD) score of 9 (P<10−11) and accounted for 29.6% of the phenotypic variation (Table 2). Thus, there was a highly significant association between NKC/H2 interaction and control of MCMV infection in this second cross, indicating that Cmv3 was also present in the FVB/N mouse strain and that its expression in the presence of H2k was necessary and sufficient for viral control. Furthermore, these data suggest that the same gene encodes Cmv3 in both the MA/My and FVB/N NKC regions.
(A) Genetic analysis of MCMV infection control in FVB/N×BALB.K F2 progeny. Mice (FVB/N and BALB.K, n = 11 per strain; FVB/N×BALB.K F2, n = 137) were infected with 5,000 PFU of MCMV; the spleen viral titers were determined by plaque assay at day 3 p.i. (B) Box plots show the combined effect of the NKC and H2 loci derived from FVB/N (H2qq and NKCff) or BALB.K (H2kk and NKCcc) parental mice on the viral loads in the spleens of the F2 progeny. The median and interquartile ranges are shown. Solid dots denote outliers. The red box corresponds to the combination of NKCff and H2kk loci (P<6×10−11).
Transgenic expression of H2-Dk has a modest effect on MCMV control in the presence of H2q
Previously, we showed that activation of Ly49P-bearing reporter cells requires the H2-Dk host molecule on MCMV-infected cells –. Therefore, to better delineate the role of H2 in the host response against MCMV, we attempted in vivo rescue of the FVB/N susceptible phenotype by genetic transfer of an 11 kb H2-Dk genomic fragment cloned from AKR mice (Figure 3A). We monitored for the presence of a diagnostic 300 bp fragment corresponding to exon 3 of the H2-Dk gene to identify transgenic FVB-Tg(Dk)+ mice among the founder population (unpublished data). By surface staining of mouse embryo fibroblasts (MEF) from FVB-Tg(Dk)+ mice, we observed the normal low levels of H2-Dk expression under regular conditions (Figure 3B). However, IFN-β treatment up-regulated expression of H2-Dk on MEF cells from either FVB-Tg(Dk)+ mice or AKR mice (H2-Dk transgene donor mouse strain) to the same extent, indicating that the transgene promoter regulatory sequences were intact (Figure 3B). We also found that the level of expression of H2-Dk in splenocytes from the FVB/N transgenic mice was similar to the natural H2-Dk expression in splenocytes from MA/My or BALB.K strains (Figure 3C). Finally, we investigated the expression of transgenic H2-Dk and endogenous H2-Dq molecules in T and B cells isolated from the spleen and observed that the two MHC-I molecules were expressed in FVB-Tg(Dk)+ mice at levels similar to those found in H2q- and H2k-bearing inbred mice (Figure S4). To test whether the H2-Dk transgene is capable of stimulating the Ly49P receptor, we assessed the activation of Ly49P-bearing reporter cells and found that these cells were equally activated by MCMV-infected MEF cells from BALB.K or from FVB-Tg(Dk)+ (Figure S5A). Stimulation of Ly49P reporters was also observed upon challenge by MEFs infected with a mutant virus lacking m157 (the Ly49H ligand). However, Ly49P reporter cell stimulation was lost upon infection of MEF cells with a mutant virus lacking the m04 gene, indicating that the transgenic H2-Dk molecule also requires m04/gp34 to stimulate Ly49P, as reported (Figure S5B) .
(A) Schematic representation of the H2-Dk gene within the 11.5 kb EcoRI genomic DNA fragment from AKR mice used to generate transgenic mice. (B) Expression of H2-Dk on MEFs from FVB/N nontransgenic (FVB-Tg(Dk)−, transgenic FVB-Tg(Dk)+, and AKR (H2k) mice. MEFs from FVB-Tg(Dk)+ and wild-type littermates were prepared from PCR-typed embryos, untreated or incubated overnight with 100 U/ml IFN-β prior to analysis of H2-Dk expression by FACS. (C) H2-Dk staining on lymphocytes from FVB-Tg(Dk)− (red peak), BALB.K (dashed peak), MA/My (black peak), and FVB-Tg(Dk)+ (dotted peak) mice. Bar graph shows quantification of the percentage of H2-Dk expression from 2–3 mice per group. (D) Splenocytes from B6.H20 mice or NKC/H2 histocompatible mice were inoculated into either untreated or asialo-GM1–treated NK cell–depleted hosts. Ratio values indicate the relative survival in the test population (CFSEhigh) compared to the histocompatible control population (CFSElow) at 18 hours after injection. Three mice per group were analyzed. Statistical significance between untreated and NK-depleted mice is shown. (E) Viral load in spleens (left) and livers (right) of mice of the indicated genotypes was determined by plaque-forming assays at day 3 p.i. Data were analyzed using two-way ANOVA analysis and the two-tailed Student's test. Data are presented as mean ± SEM and P values of significant results between groups are indicated. Results shown are representative of 2–3 independent experiments.
To establish the contribution of H2-Dk to the MCMV response, we first investigated a possible modulation of the Ly49 receptor repertoire. No significant differences were found between transgenic and non-transgenic mice in terms of the frequency of the various NK cell populations tested (Figure S6). Since H2-Dk has the potential to influence licensing through its interactions with cognate Ly49 inhibitory receptors , we addressed the licensing status of wild-type and transgenic NK cells. To do this, we determined the ability of NK cells to mediate in vivo rejection of MHC class I deficient splenocytes isolated from B6.129P-H2-D1tm1Bpe H2-K1tm1Bpe (herein B6.H20) mice using a quantitative CFSE-based method . As previously described, B6.H20 mice tolerated grafted syngeneic splenocytes (Figure 3D). By contrast, both FVB-Tg(Dk)+ and FVB-Tg(Dk)− mice rejected B6.H20 splenocytes with the same efficiency, suggesting that the presence of the H2-Dk transgene does not alter the licensing status of NK cells (Figure 3D). Finally, we monitored early viral replication following MCMV infection in FVB-Tg(Dk)+ mice, along with single and double BALB-Cmv3MA/MyH2d and BALB-Cmv3MA/MyH2k congenic mice and parental MA/My mice. We observed that FVB-Tg(Dk)+ mice had a statistically significant, albeit modest, reduction in MCMV replication in the spleen (but not in the liver) compared to nontrangenic littermates; this reduction represented only a small fraction (1∶7) of the reduction observed in BALB-Cmv3MA/MyH2k congenic mice (Figure 3E). Collectively, these data demonstrated that the H2-Dk transgene was fully expressed and able to recognize and activate the Ly49P receptor in vitro; however, it only provided partial control of MCMV infection.
Transgenic expression of H2-Dk has a major effect on MCMV control in the absence of H2q
Classical MHC class I molecules are the prototype ligands for Ly49 receptors. Reporter cell assays and tetramer binding assays suggest that H2-Dk molecules elicit both activating signals, through Ly49P, and inhibitory signals, through Ly49I and Ly49V , . By contrast, H2q-encoded molecules can elicit strong inhibitory signals through Ly49I or Ly49C, but are inert to Ly49G2 , as well as to Cmv3-encoded activating receptors (Ly49P, Ly49R, and Ly49U) . Therefore, we hypothesized that the poor MCMV infection control observed in FVB-Tg(Dk)+ mice resulted from competition between the inhibitory and activating signals emanating from H2q- and H2-Dk-encoded ligands, respectively. To test this hypothesis, we crossed FVB-Tg(Dk)+ transgenic mice with B6.H20 mice, which possess targeted deletions at the H2-D and H2-K genes. This cross produced F3 progeny mice homozygous for the FVB/N NKC (Cmv3FVB), but with a different assortment of MHC class I alleles. F3 mice were either (1) deficient in endogenous MHC class I alleles in the presence or absence of the H2-Dk transgene (H20/Tg(Dk)+ or H20/Tg(Dk)−), (2) hemizygous for H2q in the presence or absence of the H2-Dk transgene (H20/q/Tg(Dk)− or H20/q/Tg(Dk)+), or (3) homozygous for H2q in the presence of the H2-Dk transgene (H2q/Tg(Dk)+) (Figure 4A and Table 1). Again, we monitored whether the frequencies of various NK cell populations were affected by the genetic makeup of F3 mice and detected no major variations in the NK cell populations, the only exception being Ly49G+ NK cells, which were barely detectable in Cmv3FVB/H20/Tg(Dk)− mice (Figure S7). Similarly, the level of H2-Dk and H2-Kk expression on splenocytes was equivalent in transgenic F3 mice with different H2 genotypes (Figure S7, right panel). By contrast, we noted that levels of H2-Dq expression on lymphocytes from homozygous H2q/Tg(Dk)+ transgenic mice were double those of hemizygous H20/q/Tg(Dk)+ transgenic mice (P = 0.001) (Figure 4B and bar graph). Despite this variation in MHC class I expression levels, licensing of NK cells from H2-Dk transgenic mice carrying no (0), one (0/q), or two (q/q) H2q alleles was equivalent, as shown by their ability to reject CFSE-labeled splenocytes from B6.H20 mice [Figure 4C right]. These results were confirmed using explanted, IL-2-activated NK cells in cytotoxicity assays against MCH class I–deficient RMA/S target cells [Figure 4C left], demonstrating that NK cells from transgenic mice with different H2 assortments sense equally the loss of MHC class I expression on target cells and therefore are equally educated .
(A) Breeding scheme for the generation of F3 mice carrying the NKC loci from FVB/N parental mice and various combinations of H2 loci. The NKC, H2, and H2-Dk transgenic loci are represented by boxes, as indicated. The parental (P) FVB-Tg(Dk)+ and B6.H20 strains were mated to generate the F1 generation. Subsequently, F2 mice carrying an homozygous FVB/N NKC locus and heterozygous for either the H2 or the H2-Dk transgene were kept and intercrossed to generate the F3 mice with different H2 assortments (H20: H2-Kb−/−Db−/−). (B) H2-Dq staining of lymphocytes from Cmv3FVB/H20/Tg(Dk)+ (H20 red peak), Cmv3FVB/H20/q/Tg(Dk)+ (H20/q, dot peak), and Cmv3FVB/H2q/q/Tg(Dk)+ mice (H2q/q, dashed peak). Histograms on the right represent the quantification of the level of H2-Dq expression analyzed in three mice per group. (C) Rejection of B6 MHC class I–deficient cells in vivo by the indicated hosts was assessed as in Figure 3, and statistically significant differences are shown. IL-2–derived NK cells from the indicated mouse strains were co-cultured with CFSE-labeled RMA/S cells. Specific lysis at the indicated effector/target ratios was assessed by staining with 7-AAD and analyzed by FACS. Values represent the mean of 2–3 mice per group. (D) Viral loads in spleens (left) and livers (right) of parental and F3 mice of the indicated genotypes were determined by plaque assay at day 3 p.i. Results shown represent five pooled experiments. Data were analyzed using two-way ANOVA analysis and the two-tailed Student's test. Significant P values for differences between groups are indicated.
To determine the influence of the various MHC class I molecules on the NK cell immune response to MCMV infection, we examined F3 mice and parental controls at early time points, particularly on day 3 p.i., when receptor-specific NK cell responses are established . On day 3, the post-infection viral titers in the spleens and livers of Cmv3FVB/H20/q/Tg(Dk)+ and Cmv3FVB/H20/Tg(Dk)− mice were indistinguishable, demonstrating that the presence of H2q dampens the effect of Cmv3FVB/H2k on the containment of virus replication (Figure 4D). By contrast, the presence of the transgene had a significant effect in the absence of endogenous class I molecules, as Cmv3FVB/H20/Tg(Dk)+ mice had close to 30-fold lower viral titers compared to Cmv3FVB/H20/q/Tg(Dk)− mice. In parallel, B6.H20 control mice, which express Ly49H, also cleared the virus load despite lacking MHC-I molecules (Figure 4D). To investigate the role of NK cells in limiting viral spread, we found that, as in MA/My mice, the control of virus load was abrogated in BALB-Cmv3MA/MyH2k and Cmv3FVB/H20/Tg(Dk)+ mice if treated with anti-asialo GM1 antibody prior to MCMV infection, demonstrating that the resistance phenotype is NK cell-dependent (Figure S8A). Indeed, we observed uncontrolled virus growth not only when MA/My mice were pretreated with anti-asialo GM1 and anti-NK1.1 antibodies, but also after they were pretreated with YE1/48 (anti-Ly49PRTV), 12A8 (anti-Ly49R), or 4D11 (anti-Ly49GT) antibodies, indicating an overlap in Ly49 receptor expression on NK cells (Figure S9) . At day 6 p.i., a time characterized by robust proliferation of receptor-specific NK cell populations responding to the virus , we found that mice expressing Cmv3 resistance (MA/My, BALB-Cmv3MA/MyH2k, and Cmv3FVB/H20/Tg(Dk)+) had cleared MCMV from the spleen (unpublished data). Furthermore, spleen cell numbers were increased 2–6-fold in these mice and BrdU uptake indicated a robust NK cell proliferation (Figure S8B). Together, our results indicate that expression of H2-Dk can rescue Cmv3-determined MCMV resistance in the absence of endogenous H2q molecules and that Cmv3/H2-Dk-mediated resistance is associated with the expansion of NK cells in response to infection.
Host H2q inhibitory signals quantitatively modulate MCMV resistance and restrict NK cell–specific proliferation upon MCMV challenge
To better define the role of H2q alleles, we compared the kinetics of viral replication in Cmv3FVB-Tg(Dk)+ transgenic mice carrying no, one, or two H2q alleles. We observed that the number of H2 alleles correlated with a quantitative increase in viral load, as early as 36 hours p.i.. On days 3 and 5 p.i., differences in viral containment among mice of the three genotypes were significant (Figure 5A).
(A) MCMV viral load in the spleens of F3 transgenic mice at the indicated time-points was determined by plaque assay and P values of significant results between groups are indicated. (B) BrdU incorporation in NKp46-gated splenocytes stained with anti-BrdU and 4D5 antibodies. Splenoytes were isolated from mice of the indicated genotypes 5 days p.i. Graph bar represents the proportions of NK cells incorporating BrdU in total splenic leukocytes with standard deviations, using three mice per group. (C) Enriched NK cells from Cmv3FVB/H20/Tg(Dk)+ mice were labeled with CFSE then adoptively transferred into Cmv3FVB/H20/Tg(Dk)+ and Cmv3FVB/H20/q/Tg(Dk)+ recipients 24 hours before infection with MCMV for 5 days. Analysis of CFSE dilution in NK cells from the spleens of infected (dashed peaks) or uninfected (solid peaks) mice. NK cell proliferation index (number of divisions of CFSE-labeled NK cells) in Cmv3FVB/H20/Tg(Dk)+ and Cmv3FVB/H20/q/Tg(Dk)+ mice. Statistically significant differences between groups are indicated. Three mice per group were analyzed and results shown are representative of two experiments. Data were analyzed using two-way ANOVA analysis and the two-tailed Student's test. Significant P values for differences between groups are indicated.
To investigate the effect of H2q molecules on NK cell specific responses against MCMV, we monitored BrdU incorporation on NK cells after MCMV infection in FVB/N WT and F3 mice carrying no, one, or two copies of H2q alleles. After 5 days p.i., NK cells were stained with the anti-Ly49ORV (4E5) monoclonal antibody, which stained around 50% of NK cells in these strains (Figure S6 and Figure S7), and with the anti-BrdU monoclonal antibody. In all mice, we observed that NK cells that incorporated BrdU were negative for the Ly49ORV antibody staining. Furthermore, the increase in BrdU incorporation was inversely proportional to the number of H2q alleles (Figure 5B). This result suggests that there is a dose-dependent inhibition of NK cell proliferation by H2q alleles in response to MCMV infection. Finally, to investigate whether host MHC-I molecules affect NK cell activity upon MCMV infection, we adoptively transferred CFSE-labeled NK cells enriched from Cmv3FVB/H20/Tg(Dk)+ donor mice into Cmv3FVB/H20/Tg(Dk)+ or Cmv3FVB/H20/q/Tg(Dk)+ recipients (Figure 5C). After 5 days p.i., donor NK cells had undergone more rounds of division in the Cmv3FVB/H20/Tg(Dk)+ recipients than the NK cells that were transferred into Cmv3FVB/H20/q/Tg(Dk)+ mice; this indicated that H2q alleles limited NK cell proliferation induced by MCMV infection (Figure 6C bar graph). Thus, NK cells carrying H2-Dk as the sole MHC class I molecule were impaired in their ability to proliferate if the recipient mice carried H2q alleles. Collectively, these results suggest that expression of host H2q molecules dampens the capacity of NK cells to protect against MCMV.
The strength of Ly49 inhibitory signals and the presence of H2-Dk-mediated activating signals modulate the NK cell response against virus infection. Our set of NKC congenic mice bore different assortments of Ly49 receptors, but carried an identical H2k resistance haplotype. (A) NK cells from BALB.K mice had a high frequency and strong binding of inhibitory Ly49 receptors, which rendered BALB.K mice most susceptible to MCMV infection. (B) NK cells from congenic BALB.Cmv3hetH2k mice carried one copy of the activating Ly49p gene, which can activate the Ly49P/H2-Dk/m04 axis, allowing for intermediate viral loads in heterozygous mice. (C) NK cells from BALB.Cmv3MA/MyH2k mice had the lowest frequency (and/or weakest binding) of inhibitory Ly49 receptors for H2k molecules and the highest frequency of activating Ly49P+ NK cells, resulting in strong control of MCMV infection. Our set of F3 mice carried different MHC-I components, but an identical Cmv3-resistance haplotype, encoding seven inhibitory and three activating Ly49 receptors, including Ly49P. (D) Engagement of inhibitory receptors in FVB-Tg(Dk)− mice resulted in inhibition of the NK cell response against MCMV. (E) In FVB-Tg(Dk)+ mice, activating signals mediated by the engagement of Ly49P by H2-Dk/m04, in the presence of inhibitory signals elicited by H2q molecules, provided a marginal enhancement of the NK cell response, and intermediate virus control. (F) In the absence of inhibitory H2q signals, H2-Dk-dependent activation of NK cells was more efficient, which resulted in strong control of MCMV infection in Cmv3FVB/H20/Tg(Dk)+ mice.
In this study, we examined the combined contribution of the NKC and H2 loci to the NK cell response against MCMV infection. We report that MCMV resistance was recapitulated in double-congenic mice and in an independent F2 cross that reconstituted the combination of Cmv3 resistance alleles and H2k. Furthermore, we established that the H2-Dk molecule is essential to the resistance phenotype, because genetically susceptible mice bearing Cmv3 were rendered resistant by acquisition of an H2-Dk transgene. However, efficient virus control was observed only in the absence of endogenous H2q molecules, whose inhibitory input quantitatively modulated virus control. Thus, MHC class I molecules play antagonistic roles in the NK response against viral infection.
Combined effect of the NKC and MHC loci on NK cell antiviral responses
The role of the MHC has been studied using panels of congenic , sub-congenic, and transgenic mice or F2 crosses with the same NKC haplotype –, . To the best of our knowledge, the present study is the first to provide formal proof of the impact of both NKC and MHC haplotypes on NK cell antiviral activities in vivo. Our study, through the use of single- and double-congenic mice, minimized differences in non-NKC or non-MHC genes. Thus, we established that the joint action of specific alleles at these two regions accounted for most of the overall phenotypic differences between the MCMV-susceptible BALB/c and MCMV-resistant MA/My mouse strains. BALB-Cmv3MA/MyH2k mice were indistinguishable from MA/My mice in terms of initial control of infection and late NK cell responses.
Although the MA/My NKC region in congenic mice encompasses more than just Ly49 genes, our data indicates that the influence of MHC alleles on MCMV-resistance stems from the capacity of MHC class I molecules to serve as ligands for Ly49 receptors. In support of this hypothesis, the F2 cross between the MCMV-susceptible FVB/N (H2q) and BALB.K (H2k) mouse strains demonstrated that FVB/N mice carried a Cmv3 resistance allele that was conditional to H2k and overridden by the H2q susceptibility allele. Within the Cmv3 region, Ly49 receptors were responsive to MHC class I ligands. On the one hand, we noticed that none of the available anti-NKG2 or anti-CD94 antibodies recognized MA/My mouse NK cells, in contrast to NK cell recognition in FVB/N mice. Nevertheless, we observed that F2 mice of the combined Cmv3FVB/H2k genotype restrained viral replication to an extent similar to that seen in MA/My mice. On the other hand, our haplotype studies ,  and new public data (http://phenome.jax.org) indicate that FVB/N and MA/My share the same Ly49 gene repertoire, including Ly49P. Consequently, it seems that NK cell responsiveness during MCMV infection varies with different NKC-MHC combinations and is optimal only with a precise combination of Ly49 receptors inherited from MA/My (or FVB/N) mice and MHC class I H2k molecules.
Role of the MHC class I molecule H2-Dk
Our results confirmed that the H2 effect was due to the MHC class 1 molecule H2-Dk. Using an 11 kb genomic fragment containing a functional H2-Dk gene, we achieved a phenotypic rescue, although the rescue was incomplete if combined with H2q alleles. The complete protective effect of H2-Dk was restored in F3 mice lacking endogenous H2q molecules. Although H2-Dk also affects the adaptive immune response, early containment of viral replication, massive NK cell proliferation, and reversal of the resistance phenotype by depletion of NK cells in FVB-H20-Tg(Dk)+ clearly support a mechanism at the level of NK cells. Because of the presence of both inhibitory and activating Ly49 receptors, several nonexclusive scenarios could account for the precise mode of action of the combined MHC class I H2-Dk and Ly49 genotypes on the NK cell response against MCMV: (1)low threshold of NK cell activation through weak H2-Dk/Ly49 inhibitory signals, (2) effective NK cell activation through H2-Dk/Ly49 activating signals, and (3) interplay between H2-Dk/Ly49 activating and inhibitory signals.
One possibility is that MHC class I/inhibitory Ly49 signals have a negative impact on the NK cell response to MCMV. In our study, mature NK cells in BALB.K mice (which are the most susceptible to MCMV infection) express three inhibitory receptors: Ly49A, Ly49C, and Ly49G2, which all bind to MHC-I H2k molecules , , . Thus, the majority of NK cells from BALB.K mice should be inhibited by a receptor for a self-ligand. Indeed, we have recently shown that deletion of the m04 gene renders BALB.K mice resistant to MCMV infection, as the protein it encodes abolishes NK cell activation via the “missing-self” recognition mechanism (Babic et al., 2010) . The m04/gp34 protein escorts MHC class I molecules to the surface of infected cells, thus maintaining a level of surface MHC expression sufficient enough to trigger inhibitory NK cell receptors . Thus, with only three (Ly49V, Ly49I, and Ly49G2) out of seven Ly49 inhibitory receptors able to recognize H2-Dk molecules, NK cells from BALB.Cmv3MA/My H2k mice should be less susceptible to inhibition by H2k binding (Figure 6A–6C).
The existence of an H2-Dk–mediated activating axis to MCMV resistance is supported by the gain-of-function phenotype of FVB-H2-Dk transgenic mice, which presented itself despite their Ly49 repertoire that is virtually identical to that of their non-transgenic littermates (Figure S6A and S6B). Furthermore, the absence of NK cell triggering through inhibitory Ly49 receptors was not sufficient to allow efficient control of MCMV replication, as demonstrated by the F3 Cmv3FVB MHC class I–deficient mice. Most NK cells that develop in MHC class I–deficient hosts are unable to respond to MHC class I–deficient targets. However, a recent study demonstrated that, in the context of MCMV infection, NK cells eliminate virally infected cells in MHC class I–negative hosts, in addition to regaining the ability to eliminate MHC class I–deficient hematopoietic host cells . This mechanism seems to be triggered by the inflammatory milieu induced by MCMV infection . These observations suggest that the susceptibility of Cmv3FVB MHC class I–deficient F3 animals to MCMV infection is not due to a defect in education but to the absence of an activation axis, which is provided by H2-Dk.
Interplay of inhibitory and activating signals
Activating signals, mediated by the engagement of Ly49P by H2-Dk/m04, provided only a marginal enhancement of the NK cell response in the presence of H2q. Interestingly, we observed a gene dosage effect in the inhibitory action of H2q that correlated with the level of surface expression of this MHC class I molecule. However, H2q copy number did not affect the ability of NK cells from H2-Dk transgenic mice (FVB or F3) to eliminate MHC class I deficient target cells; this indicates that H2q gene dosage does not alter education/licensing of NK cells. By contrast, adoptive transfer experiments demonstrated that H2q alleles expressed on host cells limit the ability of NK cells to respond to MCMV infection, indicating that the H2q effect influences NK cell recognition of class I ligands on target cells. This suggests that H2q inhibitory signals dominate over H2-Dk-dependent activating signals emanating from MCMV-infected cells. One possibility is that H2q inhibitory signals are stronger and/or more frequent than H2k-dependent activating signals. Indeed, it has been shown that both the density and the avidity of inhibitory Ly49-ligand pairs determine the strength of inhibition . Alternatively, H2q MHC class I molecules could compete with H2-Dk for binding with the m04 protein and thus blunt the m04/H2-Dk-Ly49P activating axis. We have noted that Ly49P reporter cells are equally stimulated by MCMV-infected MEFs of H2k or H2k/q genotype, which may indicate otherwise (Figure S5). However, these results might not reflect the effect of H2q molecules on the H2-Dk/m04 complex under physiological conditions. While the molecular details of H2q inhibition of NK cell function remain unclear, our results suggest a model in which two antagonistic mechanisms are at play in NKC-H2-determined resistance to virus infection (Figure 6). One involves enhanced NK cell responses through H2-Dk-mediated activating signals. The other involves dampened NK cell responses through inhibitory Ly49 receptors stimulated by class I H2q (or H2d) molecules, which override the effect of the H2-Dk construct.
It is puzzling that Ly49 receptors can sense MHC class I molecules on infected cells despite immune-evasion mechanisms elaborated by MCMV that downregulate surface expression of MHC class I molecules. Indeed, mouse strain–specific  and cell type–specific  differences have been reported in the ability of immunoevasins to inhibit lysis of infected cells by CTLs, indicating that the efficiency of MHC class I downregulation during MCMV infection  is context dependent. In vivo MCMV replication occurs in a multitude of cell types, and perhaps the ability of the virus to achieve immune avoidance selectively might contribute to the delicate equilibrium of coexistence it has established with the host.
The striking similarities between Ly49 and KIR interactions with their respective MHC-I ligands and how they both affect NK cell function prompted us and other researchers to use the mouse as a model to study NK cell antiviral responses. Our results lend support to clinical and epidemiological studies implicating KIR-HLA interactions of different strengths in determining a hierarchy of NK cell activation with varied effects on the host response against herpersviruses , HCV , and HIV . Our work also highlights the ability of inhibitory signals to overcome NK cell activation. These regulatory mechanisms would be relevant in conditions where NK cell activation is undesirable during infection or immune disease. For example, activating KIR genotypes have been found to predispose to reactivation of quiescent, opportunistic infections associated with herpesvirus infections in HIV patients ), and to fatal outcome following Ebola virus infection ; furthermore, they may constitute a risk factor for susceptibility to autoimmunity and certain cancers , . Ultimately, our data indicate that, as has been proposed for cancer and autoimmunity, manipulating the balance between inhibitory and activating NK receptor signals represents a possible avenue to harness the therapeutic potential of NK cells against virus infections.
Materials and Methods
The animal protocols and experiments were approved by the Canadian Council on Animal Care (CCAC) and the McGill University Animal Resources Center.
MA/My, BALB.K, BALB/c, C57Bl/6 (B6), DBA/J, and AKR mice were purchased from The Jackson Laboratory. FVB/N mice were purchased from Charles Rivers Laboratories. The B6 mice deficient for H2-DbKb (B6.H20) were kindly provided by Hidde L. Ploegh (Cambridge, Massachusetts).
Generation and genetic characterization of congenic mice
BALB-Cmv3MA/MyH2k and BALB-Cmv3MA/MyH2d were generated by backcrossing the (MA/MyXBALB.K) F1 or (MA/MyXBALB/c) F1 into BALB.K or BALB/c, respectively, for at least ten generations. At each backcross, inheritance of the NKC from parental MA/My mice was genotyped using either the Ly49e marker or the D6mit135 marker . In the progeny, the introgressed portion from parental MA/My mice, which included the NKC, was analyzed using microsatellite markers or by detecting known SNPs. Once the genetic region was reduced from 34 Mb (between D6MIT36 and D6MIT59) to 10 Mb (between rs13479016 and rs13479061 SNPs), heterozygous mice were intercrossed to generate the homozygous congenic lines.
Generation of FVB-Tg(Dk) transgenic mice and derived F3 strains
The H2-Dk genomic fragment cloned into the PBR22 plasmid was kindly provided by Bernd Arnold (Deutsches Krebsforschungszentrum [DKFZ], Heidelberg, Germany). The 11.5 kb fragment encompassing the Dk gene was subsequently purified and injected into fertilized FVB/N mouse eggs. Transgenesis was performed at the Quebec Transgenesis Research Network (QTRN). Transgenic founders were screened by PCR with the primers 5′-cacacgatccagcggctgt-3′ and 5′-ggcccggtctctctctgcag-3′, specific for H2-Dk exon 3. They were then bred to FVB/N WT mice. To generate F3 mice, FVB-Tg(Dk) and B6.H20 mice were bred to produce F1 and F2 progeny. To discriminate between the NKC and H2 regions inherited from the parental strains, the F2 mice were genotyped at the NKC region with the D6Mit61 and D6Mit52 markers and at the H2 region with the D17Mit51 marker; they were also genotyped for the presence or absence of the H2-Dk transgene. Only the mice homozygous for the FVB/N NKC and heterozygous for either the H2 or the H2-Dk transgene were kept to generate the F3 progeny, as listed in Table 1.
Antibodies and flow cytometry
To prepare splenic leukocytes, spleens were removed aseptically then gently mashed through a 70 µm nylon mesh (BD Bioscience). Red blood cells were lysed with ammonium chloride (Sigma). To isolate lymphocytes from mouse blood, mice were bled from the cheek; blood was collected in RPMI medium containing 15 mM EDTA. Lymphocytes were collected after gradient centrifugation using Histopaque-1077 (Sigma). Fc receptors were blocked with 2.4G2 antibody prior to staining with specific monoclonal antibodies. NK cells were incubated with NKp46 (conjugated to phycoerythrin [PE] or fluorescein isothiocyanate [FITC]) and specific monoclonal antibodies against Ly49A-Biot (YE148), Ly49A/D (12A8), Ly49CIH (14B11), Ly49D (4E5), Ly49G2 (4D11 or AT8), NKG2A/C/E (20d5) or NKG2A/B6 (16A11), CD94 (18D3), or KLRG1 (2F1). NK cells were also incubated with the following isotype control monoclonal antibodies: PE-conjugated golden syrian hamster IgG, FITC- or PE-conjugated mouse IgG2a K, or FITC-conjugated rat IgG2a K (e-Bioscience). H2-Dk and -Dq products were detected by anti-H2-Dk antibody (15-5-5) from BioLegend and anti-H2-Dq antibody (KH117) from e-Bioscience. To detect incorporated BrdU on NK cells, mice were scarified 5 or 6 days after MCMV infection; cells were first stained for surface antigens (anti-NKp46 and/or anti-Ly49 receptors) and then fixed, permeabilized, treated with DNase I, and stained with FITC- or allophycocyanin (APC)-conjugated anti-BrdU antibody (clone 3D4; BD Biosciences), according to the manufacturer's protocol. Flow cytometry analysis was performed with a FACSCalibur flow cytometer (BD Biosciences) and data were analyzed using CellQuest (BD Biosciences) or FlowJo (Tree Star). To assess NK cell proliferation in vivo, NK cells from the spleen were first enriched by negative selection (Miltenyi Biotec), then incubated with 5 µM CFSE for 15 minutes, washed, and resuspended in PBS. The purity of the NK cells (55%–70%) was evaluated by FACS using anti-NKP46 antibody; 2 million NK cells were then injected intravenously into recipient mice 24 hours before infection with MCMV. The proliferation index, indicating the number of divisions of CFSE-labelled NK cells, was determined using the FlowJo software.
Viruses and infections
Stock MCMV from mouse salivary glands was prepared by passaging the virus (Smith strain ATCC VR-1399, lot 1698918) twice in BALB/c mice. The virus was prepared from a homogenate of salivary glands 21 days p.i.. Mice aged between 7 and 9 weeks were infected intraperitoneally with 2,000 PFUs of MCMV. The tissue culture-grown viruses  Δm157 MCMV, which lacks the m157 open reading frame (ORF), and Δm04 MCMV, which lacks the m04 ORF, have been previously described ,  and were kindly donated by Ulrich H. Koszinowski (Max von Pettenkofer Institute, Munich, Germany) and Stepan Jonjic (Rijeka University, Rijeka, Croatia). Viral titers of the stock virus or mouse organs (spleen and liver) were evaluated in vitro by standard plaque assays on a confluent BALB/c MEF monolayer, as previously described .
MEFs: MCMV infection and reporter cell assay
The MEFs used in this work were generated as previously described , except for FVB-Tg(Dk)+ transgenic and nontransgenic MEF cells, which were generated from individuals embryos from the progeny of FVB-Tg(Dk)×FVB wild-type mouse crosses and then genotyped for the presence of the H2-Dk transgene. 2B4 reporter cells expressing Ly49H, Ly49P, Ly49C, or Ly49I were generated as previously described , , . MEF cultures from AKR, FVB/N H2-Dk transgenic, FVB/N wild-type, and BALB.K mice were infected with MCMV (Smith strain) or Δm157 or Δm04 deletion viruses at a multiplicity of infection (MOI) of 1.0 for 24 hours; they were used to stimulate 2B4 reporter cells as previously described . GFP was detected by flow cytometry and analyzed using the FlowJo software.
In vivo killing of CFSE-labeled MHC class I–deficient cells
Splenocytes from B6.H20 mice were labeled with 0.4 mM CFSE (CFSE low) in RPMI medium containing 5% FCS; splenocytes from recipient mice were labeled with 4 mM CFSE (CFSE high) in RPMI containing 10% FCS. The splenocytes were then incubated at 37°C for 10 minutes before being washed three times in RPMI containing 10% FCS. Cells (5×106) of each type were mixed, and the mixture (200 µl) was injected intravenously into recipient mice. After 18 hours, spleens were harvested and red blood cells were lysed. The relative percentage of cells in each CFSE population was measured by FACS as previously described .
In vitro killing of CFSE-labeled RMA/S cells
NK cells from the spleen were expanded for 5 days in RPMI medium supplemented with 1,000 U/ml human IL-2 (NCI Preclinical Repository). Cells were washed in RPMI and stained with NKp46 antibody to determine the purity of NK cells and to adjust the number of NK cells among strains. RMA/S cells were labeled with 0.4 mM CFSE in RPMI medium containing 5% FCS for 15 minutes at 37°C and washed three times. CFSE-RMA/S and NK cells were cocultured at effector/target ratios of 2∶1, 4∶1, 8∶1, 16∶1, and 32∶1 for 4 hours at 37°C. Specific lysis was determined by the measure of 7-aminoactinomycin D (7-AAD) incorporation (BD) in CFSE-RMA/S cells by flow cytometry, as previously described .
For the 137 (FVB/N×BALB/c) F2 mice, the contribution of the NKC and H2 loci to the segregation of the phenotype was estimated with the linear model phenotype = m+NKC+H2+NKC:H2+e, where NKC and H2 represent factors that depend on the mode of inheritance proposed, m is the common mean value, NKC:H2 is an interaction term, and e is the independent, normally distributed random deviations. For the additive mode of inheritance, the NKC and H2 represent the number of FVB/N/BALB.K alleles at each locus. For the recessive mode of inheritance, the NKC and H2 are indicator variables of the homozygous FVB/N and BALB.K backgrounds, respectively. The four possible additive-recessive combinations of H2-NKC models, with and without an interaction term, were fitted. We assessed the magnitude of the contribution for each term in the model by its P value, obtained by 1 million bootstrapped samples, and partial η2. Partial η2 was computed as η2 = SSfactor/(SSfactor+SSerror), where SSfactor is the type 3 associated sum of squares with the factor in the analysis of variance (ANOVA) table, and SSerror is the sum of squares corresponding to the residual variation. We carried out statistical and graphical analyses using R software. For other statistical analyses in this work, differences between groups were calculated with two-way ANOVA analysis, followed by Bonferroni after tests. For some of the analyses, unpaired, two-tailed Student's t-tests were conducted. Results with a P value of <0.05 were considered to be statistically significant.
Binding of Ly49-specific monoclonal antibody to MA/My activating receptors. cDNAs encoding MA/My Ly49P, Ly49R and Ly49U receptors were expressed in NFAT-GFP 2B4 T-cell hybridomas . Expression of the three receptors was detected by the anti-Flag M2 monoclonal antibody. Binding of the isotype control monoclonal antibody (red histogram) or the indicated Ly49-specific monoclonal antibody (black histogram) to Ly49P, Ly49R, and Ly49U receptors was assessed by flow cytometry and analyzed using Flowjo software. The percentage of binding is indicated in each histogram.
(1.19 MB EPS)
Frequencies of Ly49+ and KLRG1+NK cells in double congenic mice. Quantification of expression frequency of indicated NK receptors in the parental MA/My strain and BALB-Cmv3MA/MyH2k and BALB-Cmv3MA/MyH2d congenic mice. Data are presented as mean ± SEM and P values of significant differences between groups are indicated.
(0.89 MB EPS)
Lack of NKG2A/C/E and CD94 antibody staining on NK cells from MA/My mice. (A) NKG2A/C/E and CD94 expression on NKp46+ NK cells from MA/My, FVB/N, and DBA/2J (as they carry a NKG2/CD94 deficiency ) mice was determined by flow cytometry using the indicated monoclonal antibodies. (B) CD94 and NKG2A RNA expression in enriched NK cells from the indicated mice strains was analyzed by RT-PCR. β-actin was used as an internal control.
(0.87 MB EPS)
Ly49P+2B4 reporter cell stimulation by MCMV-infected MEF cells produced from FVB-Tg(Dk)+ mice. (A) Stimulation of Ly49P reporter cells by co-culture with MEF cells from the indicated backgrounds that were uninfected (black histograms) or MCMV infected at an MOI of 1 for 24 h (grey histograms). Ly49P-specific activation was detected by NFAT-GFP expression using flow cytometry. (B) Stimulation of Ly49P or Ly49H reporter cells by co-culture with FVB-Tg(Dk)+ MEF cells that were uninfected (left) or infected with Δm157 (middle) or Δm04 (right) MCMV deletion mutants. Reporter cell stimulation was detected by monitoring expression of GFP by flow cytometry. The percentage of positive cells in each gated population is indicated.
(0.87 MB EPS)
Co-expression of H2-Dq and H2-Dk in FVB-Tg(Dk)+ mice. Endogenous H2-Dq (bottom) and transgenic H2-Dk (top) expression in splenic T and B cells from FVB-Tg(Dk)+ transgenic (black peak) or nontransgenic (black peak) littermates was determined by flow cytometry.
(0.57 MB EPS)
Ly49 receptor expression on NK cells from FVB H2-Dk transgenic and nontransgenic mice. (A) The indicated Ly49 specific monoclonal antibodies (black peak) or isotype controls (red peak) were gated on NKp46+ splenic NK cells from FVB-Tg(Dk)− and FVB-Tg(Dk)+ mice and analyzed by FACS. The proportion of Ly49 receptor expression is indicated in each histogram. (B) Quantification of expression frequency of the indicated NK receptors in FVB-Tg(Dk)− and FVB-Tg(Dk)+ mice.
(1.81 MB EPS)
Ly49 receptor and MHC class I expression on NK cells from F3 mice. The indicated Ly49-specific monoclonal antibodies were gated on NKp46+ splenic NK cells from F3 mice and the proportion of expression is indicated in each histogram. Right panels: expression of MHC-I H2-Dq and H2-Dk molecules on total splenocytes was determined. 2–3 mice per genotype were analyzed. We found that the expression of the activating and the inhibitory receptors were almost comparable between strains for the exception of Ly49G which was barely detectable in the Cmv3FVB/H20/Tg(Dk)− mice using both anti- Ly49G antibodies (LGL-1 and AT8 (data not shown)). This receptor is perfectly expressed in the B6.H20 parental strain (data not shown) and doesn't seem to be correlated with a defect of NK maturation since the Killer cell lectin-like receptor G1 (KLRG1) is equally expressed between the Cmv3FVB/H20/Tg(Dk)+ and the Cmv3FVB/H20/Tg(Dk)− mice.
(1.37 MB EPS)
NK cell–dependent MCMV infection control in congenic and F3 mice. (A) Viral loads in spleens (top) and livers (bottom) 3 d post-infection in MCMV-resistant MA/My progenitor, BALB-Cmv3MA/MyH2k congenic, and Cmv3FVB/H20/Tg(Dk)+ transgenic mice that were NK cell depleted (white squares) or not (black circles) with anti-asialo GM1 antibody. (B) Number of NK cells per spleen (top) and BrdU incorporation (bottom) at 7 d post-MCMV infection in MCMV-resistant mice of the indicated genotypes. For the number of NK cells, data are presented as mean ± SEM and statistically significant differences between groups are indicated. For BrdU incorporation data are represented by fold increase between noninfected and infected animals. Results shown are representative of 1–2 experiments.
(1.56 MB EPS)
Effect of Ly49-specifc monoclonal antibody depletion in MA/My mice during the course of MCMV infection. MCMV viral load was assessed in untreated MA/My mice (mock) or treated with the indicated monoclonal antibody prior to MCMV infection. Viral load in spleen was determined by plaque assay after 3 d of infection.
(1.47 MB EPS)
We thank Patricia D'Arcy and Chantal Lacroix for excellent help with animal experiments and maintenance, H. Ploegh (Harvard University) for MHC class I–deficient mice, as well as Seung-Hwan Lee (Brown University) and Michal Pyzik (McGill University) for their critical review of this manuscript. We also thank Kira Heller and Eve-Marie Gendron Pont-Briand for editorial and proofreading services.
Conceived and designed the experiments: NFC SMV. Performed the experiments: NFC. Analyzed the data: NFC JCLO SMV. Wrote the paper: NFC SMV.
- 1. Raulet DH, Guerra N (2009) Oncogenic stress sensed by the immune system: role of natural killer cell receptors. Nat Rev Immunol 9: 568–580.
- 2. Lodoen MB, Lanier LL (2006) Natural killer cells as an initial defense against pathogens. Curr Opin Immunol 18: 391–398.
- 3. Guan H, Moretto M, Bzik DJ, Gigley J, Khan IA (2007) NK cells enhance dendritic cell response against parasite antigens via NKG2D pathway. J Immunol 179: 590–596.
- 4. Vankayalapati R, Garg A, Porgador A, Griffith DE, Klucar P, et al. (2005) Role of NK cell-activating receptors and their ligands in the lysis of mononuclear phagocytes infected with an intracellular bacterium. J Immunol 175: 4611–4617.
- 5. Gonzalez VD, Landay AL, Sandberg JK (2010) Innate immunity and chronic immune activation in HCV/HIV-1 co-infection. Clin Immunol 135: 12–25.
- 6. Ward J, Barker E (2008) Role of natural killer cells in HIV pathogenesis. Curr HIV/AIDS Rep 5: 44–50.
- 7. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP (1999) Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 17: 189–220.
- 8. Ortaldo JR, Young HA (2005) Mouse Ly49 NK receptors: balancing activation and inhibition. Mol Immunol 42: 445–450.
- 9. Karre K (1991) MHC gene control of the natural killer system at the level of the target and the host. Semin Cancer Biol 2: 295–309.
- 10. Fernandez NC, Treiner E, Vance RE, Jamieson AM, Lemieux S, et al. (2005) A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 105: 4416–4423.
- 11. Yokoyama WM, Kim S (2006) How do natural killer cells find self to achieve tolerance? Immunity 24: 249–257.
- 12. Anfossi N, Andre P, Guia S, Falk CS, Roetynck S, et al. (2006) Human NK cell education by inhibitory receptors for MHC class I. Immunity 25: 331–342.
- 13. Jonsson AH, Yang L, Kim S, Taffner SM, Yokoyama WM (2010) Effects of MHC class I alleles on licensing of Ly49A+ NK cells. J Immunol 184: 3424–3432.
- 14. Raulet DH, Held W, Correa I, Dorfman JR, Wu MF, et al. (1997) Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors. Immunol Rev 155: 41–52.
- 15. Raulet DH, Vance RE, McMahon CW (2001) Regulation of the natural killer cell receptor repertoire. Annu Rev Immunol 19: 291–330.
- 16. Kim S, Poursine-Laurent J, Truscott SM, Lybarger L, Song YJ, et al. (2005) Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436: 709–713.
- 17. Yokoyama WM, Kim S (2006) Licensing of natural killer cells by self-major histocompatibility complex class I. Immunol Rev 214: 143–154.
- 18. Dokun AO, Kim S, Smith HR, Kang HS, Chu DT, et al. (2001) Specific and nonspecific NK cell activation during virus infection. Nat Immunol 2: 951–956.
- 19. Gazit R, Gruda R, Elboim M, Arnon TI, Katz G, et al. (2006) Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat Immunol 7: 517–523.
- 20. Diefenbach A, Jamieson AM, Liu SD, Shastri N, Raulet DH (2000) Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat Immunol 1: 119–126.
- 21. Smith HR, Heusel JW, Mehta IK, Kim S, Dorner BG, et al. (2002) Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci U S A 99: 8826–8831.
- 22. Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL (2002) Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296: 1323–1326.
- 23. Bubic I, Wagner M, Krmpotic A, Saulig T, Kim S, et al. (2004) Gain of virulence caused by loss of a gene in murine cytomegalovirus. J Virol 78: 7536–7544.
- 24. Fodil-Cornu N, Lee SH, Belanger S, Makrigiannis AP, Biron CA, et al. (2008) Ly49h-deficient C57BL/6 mice: a new mouse cytomegalovirus-susceptible model remains resistant to unrelated pathogens controlled by the NK gene complex. J Immunol 181: 6394–6405.
- 25. Desrosiers MP, Kielczewska A, Loredo-Osti JC, Adam SG, Makrigiannis AP, et al. (2005) Epistasis between mouse Klra and major histocompatibility complex class I loci is associated with a new mechanism of natural killer cell-mediated innate resistance to cytomegalovirus infection. Nat Genet 37: 593–599.
- 26. Kielczewska A, Pyzik M, Sun T, Krmpotic A, Lodoen MB, et al. (2009) Ly49P recognition of cytomegalovirus-infected cells expressing H2-Dk and CMV-encoded m04 correlates with the NK cell antiviral response. J Exp Med 206: 515–523.
- 27. Chalmer JE, Mackenzie JS, Stanley NF (1977) Resistance to murine cytomegalovirus linked to the major histocompatibility complex of the mouse. J Gen Virol 37: 107–114.
- 28. Dighe A, Rodriguez M, Sabastian P, Xie X, McVoy M, et al. (2005) Requisite H2k role in NK cell-mediated resistance in acute murine cytomegalovirus-infected MA/My mice. J Immunol 175: 6820–6828.
- 29. Xie X, Dighe A, Clark P, Sabastian P, Buss S, et al. (2007) Deficient major histocompatibility complex-linked innate murine cytomegalovirus immunity in MA/My.L-H2b mice and viral downregulation of H-2k class I proteins. J Virol 81: 229–236.
- 30. Klein J (1973) List of congenic lines of mice. I. Lines with differences at alloantigen loci. Transplantation 15: 137–153.
- 31. Makrigiannis AP, Pau AT, Saleh A, Winkler-Pickett R, Ortaldo JR, et al. (2001) Class I MHC-binding characteristics of the 129/J Ly49 repertoire. J Immunol 166: 5034–5043.
- 32. Johansson S, Salmon-Divon M, Johansson MH, Pickman Y, Brodin P, et al. (2009) Probing natural killer cell education by Ly49 receptor expression analysis and computational modelling in single MHC class I mice. PLoS ONE 4: e6046.
- 33. Oberg L, Johansson S, Michaelsson J, Tomasello E, Vivier E, et al. (2004) Loss or mismatch of MHC class I is sufficient to trigger NK cell-mediated rejection of resting lymphocytes in vivo - role of KARAP/DAP12-dependent and -independent pathways. Eur J Immunol 34: 1646–1653.
- 34. Hanke T, Takizawa H, McMahon CW, Busch DH, Pamer EG, et al. (1999) Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. Immunity 11: 67–77.
- 35. Xie X, Stadnisky MD, Coats ER, Ahmed Rahim MM, Lundgren A, et al. MHC class I D(k) expression in hematopoietic and nonhematopoietic cells confers natural killer cell resistance to murine cytomegalovirus. Proc Natl Acad Sci U S A 107: 8754–8759.
- 36. Webb JR, Lee SH, Vidal SM (2002) Genetic control of innate immune responses against cytomegalovirus: MCMV meets its match. Genes Immun 3: 250–262.
- 37. Jonsson AH, Yang L, Kim S, Taffner SM, Yokoyama WMEffects of MHC class I alleles on licensing of Ly49A+ NK cells. J Immunol 184: 3424–3432.
- 38. Kavanagh DG, Gold MC, Wagner M, Koszinowski UH, Hill AB (2001) The multiple immune-evasion genes of murine cytomegalovirus are not redundant: m4 and m152 inhibit antigen presentation in a complementary and cooperative fashion. J Exp Med 194: 967–978.
- 39. Sun JC, Lanier LL (2008) Cutting edge: viral infection breaks NK cell tolerance to “missing self”. J Immunol 181: 7453–7457.
- 40. Chalifour A, Roger J, Lemieux S, Duplay P (2003) Receptor/ligand avidity determines the capacity of Ly49 inhibitory receptors to interfere with T-cell receptor-mediated activation. Immunology 109: 58–67.
- 41. Hasan M, Krmpotic A, Ruzsics Z, Bubic I, Lenac T, et al. (2005) Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein. J Virol 79: 2920–2930.
- 42. LoPiccolo DM, Gold MC, Kavanagh DG, Wagner M, Koszinowski UH, et al. (2003) Effective inhibition of K(b)- and D(b)-restricted antigen presentation in primary macrophages by murine cytomegalovirus. J Virol 77: 301–308.
- 43. Pinto AK, Munks MW, Koszinowski UH, Hill AB (2006) Coordinated function of murine cytomegalovirus genes completely inhibits CTL lysis. J Immunol 177: 3225–3234.
- 44. Gazit R, Garty BZ, Monselise Y, Hoffer V, Finkelstein Y, et al. (2004) Expression of KIR2DL1 on the entire NK cell population: a possible novel immunodeficiency syndrome. Blood 103: 1965–1966.
- 45. Khakoo SI, Thio CL, Martin MP, Brooks CR, Gao X, et al. (2004) HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305: 872–874.
- 46. Carrington M, Martin MP, van Bergen J (2008) KIR-HLA intercourse in HIV disease. Trends Microbiol 16: 620–627.
- 47. Price P, Witt C, de Santis D, French MA (2007) Killer immunoglobulin-like receptor genotype may distinguish immunodeficient HIV-infected patients resistant to immune restoration diseases associated with herpes virus infections. J Acquir Immune Defic Syndr 45: 359–361.
- 48. Wauquier N, Padilla C, Becquart P, Leroy E, Vieillard V (2010) Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection. Immunogenetics 62: 767–771.
- 49. Nelson GW, Martin MP, Gladman D, Wade J, Trowsdale J, et al. (2004) Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis. J Immunol 173: 4273–4276.
- 50. Baessler T, Charton JE, Schmiedel BJ, Grunebach F, Krusch M, et al. (2010) CD137 ligand mediates opposite effects in human and mouse NK cells and impairs NK-cell reactivity against human acute myeloid leukemia cells. Blood 115: 3058–3069.
- 51. Fodil-Cornu N, Pyzik M, Vidal SM (2010) Use of inbred mouse strains to map recognition receptors of MCMV infected cells in the NK cell gene locus. Methods Mol Biol 612: 393–409.
- 52. Brune W, Hengel H, Koszinowski UH (2001) A mouse model for cytomegalovirus infection. Curr Protoc Immunol Chapter 19: Unit 19 17.
- 53. Wagner M, Gutermann A, Podlech J, Reddehase MJ, Koszinowski UH (2002) Major histocompatibility complex class I allele-specific cooperative and competitive interactions between immune evasion proteins of cytomegalovirus. J Exp Med 196: 805–816.
- 54. Depatie C, Chalifour A, Pare C, Lee SH, Vidal SM, et al. (1999) Assessment of Cmv1 candidates by genetic mapping and in vivo antibody depletion of NK cell subsets. Int Immunol 11: 1541–1551.
- 55. Kielczewska A, Kim HS, Lanier LL, Dimasi N, Vidal SM (2007) Critical residues at the Ly49 natural killer receptor's homodimer interface determine functional recognition of m157, a mouse cytomegalovirus MHC class I-like protein. J Immunol 178: 369–377.
- 56. Babic M, Pyzik M, Zafirova B, Mitrovic M, Butorac V, et al. (2010) Cytomegalovirus immunoevasin reveals the physiological role of “missing self” recognition in natural killer cell dependent virus control in vivo. J Exp Med 207: 2663–2673.
- 57. Vance RE, Jamieson AM, Cado D, Raulet DH (2002) Implications of CD94 deficiency and monoallelic NKG2A expression for natural killer cell development and repertoire formation. Proc Natl Acad Sci U S A 99: 868–873.